Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

1. WHO recommendation on Calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications

to pregnancy. The cost-effectiveness of this intervention is not known. Remarks • The GDG noted that in 2018 WHO revalidated the recommendation that in populations with low dietary calcium intake, daily calcium supplementation (1.5–2.0 g oral elemental calcium) is recommended for pregnant women to reduce the risk of pre-eclampsia (1). However, there is insufficient evidence to determine with precision at what gestational age calcium supplementation should be commenced in order to confer this benefit (...) of their enjoyment of sexual and reproductive health and rights, and living a life of dignity (4). The World Health Organization (WHO) envisions a world where “every pregnant woman and newborn receives quality care throughout the pregnancy, childbirth and the postnatal period” (5). There is evidence that effective interventions exist at reasonable cost for the prevention or treatment of virtually all life-threatening maternal complications (6). Almost two thirds of the global maternal and neonatal disease burden

2020 World Health Organisation Guidelines

2. Advice for pregnant members of the anaesthesia and intensive care workforce during the COVID-19 pandemic

Advice for pregnant members of the anaesthesia and intensive care workforce during the COVID-19 pandemic 1 Occupational health advice for employers and pregnant women during the COVID-19 pandemic Version 3: Published Tuesday 21 April 2020 COVID-19 virus infection and pregnancy2 Updates Please note that version 1 of this occupational health guidance was published as a chapter in the RCOG’s general Coronavirus (COVID-19) Infection in Pregnancy guidance. The occupational health guidance will now (...) professionals on employment rights. Such information can be obtained from trade unions or from charities. In particular, relevant information about employment rights for pregnant healthcare workers is available from the RCM. This guidance aims to provide employers and pregnant women with information and available clinical evidence on the risks of continuing to work during the COVID-19 pandemic. 2. Available information about risks of contracting COVID-19 in pregnancy COVID-19 poses a risk to all members

2020 ICM Anaesthesia COVID-19

3. National Clinical Guideline on stratification of clinical risk in pregnancy

National Clinical Guideline on stratification of clinical risk in pregnancy National Clinical Guideline on stratification of clinical risk in pregnancy | HIQA Header Tasks Menu COVID-19 HIQA’s is supporting the National Public Health Emergency Team in its response to COVID-19. Read all our . National Clinical Guideline on stratification of clinical risk in pregnancy Search Search Main navigation Contact Us 021 240 9300 Follow Us Receive SMS News Alerts Text HIQA to 51155 to subscribe to our

2020 HIQA Guidelines

4. Pregabalin (Lyrica or other brands) and gabapentin (Neurontin or other brands): known dangers and uncertainties during pregnancy

this risk. In practice, pregabalin and gabapentin should be avoided whenever possible in women who are or could become pregnant. However, when either of these drugs is chosen during pregnancy, it is important to inform the woman of its known risks and uncertainties. If used close to delivery, it is useful to inform the delivery team so that the neonate receives the necessary monitoring. ©Prescrire 1 May 2020 Share Share Download the full review. Antiepileptics and pregnancy: potential long-term effects (...) Pregabalin (Lyrica or other brands) and gabapentin (Neurontin or other brands): known dangers and uncertainties during pregnancy Prescrire IN ENGLISH - Spotlight ''Pregabalin (Lyrica° or other brands) and gabapentin (Neurontin° or other brands): known dangers and uncertainties during pregnancy'', 1 May 2020 {1} {1} {1} | | > > > Pregabalin (Lyrica° or other brands) and gabapentin (Neurontin° or other brands): known dangers and uncertainties during pregnancy Spotlight Every month, the subjects

2020 Prescrire

5. Cesarean scar pregnancy

Cesarean scar pregnancy Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy - American Journal of Obstetrics & Gynecology Go search , PB2-B14, May 01, 2020 Powered By Mendeley Share on Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy Society for Maternal-Fetal Medicine (SMFM)pubs@smfm.org ∗ Russell Miller Affiliations The American College of Obstetricians and Gynecologists (ACOG), the American Institute of Ultrasound (...) this document Published: January 20, 2020 DOI: Cesarean scar pregnancy is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. This condition presents a substantial risk for severe maternal morbidity because of challenges in securing a prompt diagnosis, as well as uncertainty regarding optimal treatment once identified. Ultrasound is the primary imaging modality for cesarean scar pregnancy diagnosis, although a correct and timely determination can be difficult

2020 Society for Maternal-Fetal Medicine

6. Coronavirus (COVID-19) infection and pregnancy

Coronavirus (COVID-19) infection and pregnancy 1 Information for healthcare professionals Version 9: Published Wednesday 13 May 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Contents Summary of updates 3-5 1. Introduction 6-11 2. Advice for health professionals to share with pregnant women 12-19 3. Advice for all midwifery and obstetric services caring for pregnant women 20-36 4. Advice for services caring for women with suspected or confirmed COVID-19 37-39 Acknowledgements 40 Appendix 1 (...) for antibiotics at presentation, with early review and rationalisation of antibiotics if COVID-19 is confirmed.’ 9 13.5.20 3.6: Statement added: ‘A woman with moderate or severe COVID symptoms who happens to be pregnant but with no immediate pregnancy issue should be cared for by the same multidisciplinary team as a non-pregnant woman with additional input from the maternity team. The labour ward should not be the default location for all pregnant women.’6 1. Introduction7 1. Introduction The following advice

2020 Royal College of Obstetricians and Gynaecologists

7. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial Full Text available with Trip Pro

):CD003511. doi: 10.1002/14651858.CD003511.pub3. Cochrane Database Syst Rev. 2013. PMID: 24173668 Updated. Review. Show more similar articles References Wilcox AJ. Fertility and Pregnancy: An Epidemiologic Perspective. Oxford: Oxford University Press; 2010. Wilson R, Jenkins C, Miller H, McInnes IB, Moore J, McLean MA, et al. Abnormal cytokine levels in non‐pregnant women with a history of recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2004;115:51–4. - Jurkovic D, Overton C, Bender‐Atik R (...) The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial The Cost-Effectiveness of Progesterone in Preventing Miscarriages in Women With Early Pregnancy Bleeding: An Economic Evaluation Based on the PRISM Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2020 EvidenceUpdates

8. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review

Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info Close Account Logged (...) . Online ahead of print. Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review , , , Affiliations Expand Affiliations 1 Department of Obstetrics, Chengdu Jinjiang Maternity and Child Health Hospital, Chengdu, China. 2 The First Clinical College of Chongqing Medical University, Chongqing, China. 3 North Sichuan Medical College, Nanchong, China. PMID: 32354293 DOI: Item in Clipboard Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review Ziyi Yang et al. J Matern Fetal

2020 EvidenceUpdates

9. Tobacco and Nicotine Cessation During Pregnancy

), and non-Hispanic American Indian or Alaska Native women (16.7%) . Pregnant women should be advised of the significant perinatal risks associated with tobacco use, including orofacial clefts, fetal growth restriction, placenta previa, abruptio placentae, preterm prelabor rupture of membranes , low birth weight, increased perinatal mortality , ectopic pregnancy , and decreased maternal thyroid function . An estimated 5–8% of preterm deliveries, 13–19% of term infants with low birth weight, 22–34% cases (...) , and provide behavioral interventions for those who smoke . The U.S. Public Health Service recommends that clinicians offer effective tobacco cessation interventions to pregnant women who smoke at the initial prenatal visit and throughout the course of pregnancy . Addiction to and dependence on cigarettes is physiologic and psychologic, and cessation techniques should include psychosocial interventions and pharmacologic therapy. Two counseling techniques with positive effects on smoking and nicotine

2020 American College of Obstetricians and Gynecologists

10. ASCIA Guidelines - Acute management of anaphylaxis in pregnancy

the pregnant and non-pregnant population. A dose of 0.5mg adrenaline intramuscularly (IM) can be given for treatment of anaphylaxis in pregnancy. Anaphylaxis definitions Any acute onset illness with typical skin features (urticarial rash or erythema/flushing, and/or angioedema), PLUS involvement of respiratory and/or cardiovascular and/or persistent severe gastrointestinal symptoms; or Any acute onset of hypotension or bronchospasm or upper airway obstruction where anaphylaxis is considered possible, even (...) ASCIA Guidelines - Acute management of anaphylaxis in pregnancy ASCIA Guidelines Acute Management of Anaphylaxis in Pregnancy - Australasian Society of Clinical Immunology and Allergy (ASCIA) | | ASCIA Guidelines Acute Management of Anaphylaxis in Pregnancy There are limited studies exploring the management of patients with anaphylaxis and in particular anaphylaxis in pregnancy. These guidelines are intended for medical practitioners, midwives and nurses providing first responder emergency care

2020 Australasian Society of Clinical Immunology and Allergy

11. Updated advice regarding PPE to be worn when managing pregnant women with known or suspected COVID-19

Updated advice regarding PPE to be worn when managing pregnant women with known or suspected COVID-19 PPE Jargon Buster FRSM fluid resistant surgical mask FRDG fluid resistant disposable gown PPE personal protective equipment AGP aerosol generating procedure FFP mask filtering face piece respirator 11 April 2020 | Dr Nuala Lucas, Dr Jim Bamber, Dr Fiona Donald, Dr Felicity Platt | icmanaesthesiacovid-19.orgChoice of PPE for obstetric anaesthetists according to mode of transmission risk Non

2020 ICM Anaesthesia COVID-19

12. Lithium during pregnancy: malformations, fetotoxicity and uncertain long-term effects

 |   |  Spotlight Lithium during pregnancy: malformations, fetotoxicity and uncertain long-term effects FEATURED REVIEW Outside the context of pregnancy, lithium is the standard "mood stabiliser" for the treatment of bipolar disorder. What are the main known short-term and long-term consequences of in utero exposure to lithium? Full review (3 pages) available for download by subscribers. Abstract A meta-analysis of about 600 pregnant women exposed to lithium during the first (...) trimester of pregnancy, from six cohorts, showed that lithium roughly doubled the risk of major malformations. Another study in about 700 pregnant women with first-trimester exposure showed that doses of lithium above 600 mg per day increased the risk of congenital heart defects, in particular Ebstein's anomaly. Second- and third-trimester exposure increases the risk of polyhydramnios. Seizures, hypotonia, and heart rate and heart rhythm disorders are foreseeable. Various neonatal complications

2020 Prescrire

13. Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19

Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19 Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19 On March 17, 2020, the Royal College of Obstetricians and Gynecologists (RCOG) updated their guidance on Coronavirus (COVID-19) Infection in Pregnancy to include information for health care providers regarding water birth. This guidance states that “the use of birthing pools in hospital should be avoided in suspected (...) or confirmed cases, given evidence of transmission in faeces and the inability to use adequate protection equipment for healthcare staff during water birth.” (1) The RCOG opinion does not concern the feasibility of water birth for the well pregnant person during the COVID-19 pandemic. Rather, this opinion specifically indicates the use of birthing pools in hospitals should be avoided if the pregnant person has suspected or confirmed COVID-19. Although not explicitly stated, presumably this means

2020 Ontario Midwives

14. Updated SOGC Committee Opinion – COVID-19 in Pregnancy

on how to prevent or manage infection with COVID-19. Due to physiologic changes that occur in pregnancy, when compared with their non-pregnant counterparts, pregnant women with lower respiratory tract infections often experience worse outcomes, including higher rates of hospital and intensive care unit admission. (3) Since 2002 there have been two other global outbreaks of highly-pathogenic coronaviruses: severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). While SARS (...) with SARS and MERS infection. The only published case-control study showed that pregnant women with SARS experienced worse outcomes than non-pregnant women of similar age.(10) Reports varied with respect to the effects of SARS and MERS on pregnancy outcomes. Spontaneous abortion has been reported among women infected with SARS and MERS in the first trimester.4 As well, stillbirth, intrauterine growth restriction, and preterm birth have been reported in pregnancies affected by SARS and MERS in the second

2020 Society of Obstetricians and Gynaecologists of Canada

15. Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know

- guidance.html). What is known about COVID-19 in pregnancy? Currently, there is limited information from published scientific reports about the susceptibility of pregnant women to COVID-19 and severity of infection. Available data are still limited to small case series. In general, pregnant women experience immunologic and physiologic changes that make them more susceptible to viral respiratory infections. The initial characterization of pregnant women as a high-risk group was based largely on this fact (...) potentially lower risk in pregnant women, but these series included a total of only 18 patients and must be interpreted with caution 7, 8 . At present, there is no evidence that pregnancy increases a woman’s risk of acquiring COVID-19 or developing severe symptoms from the disease. Anecdotal experience in the United States indicates that pregnant women are as likely as the general public to develop symptoms if infected with coronavirus; symptoms are likely to be mild to moderate, as is true

2020 Society for Maternal-Fetal Medicine

16. Definitions of infertility and recurrent pregnancy loss: a committee opinion

Definitions of infertility and recurrent pregnancy loss: a committee opinion De?nitions of infertility and recurrent pregnancy loss: a committee opinion Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Thisdocumentcontainsthede?nitionsofinfertilityandrecurrentpregnancylossasde?nedbythePracticeCommitteeoftheAmericanSo- ciety for Reproductive Medicine. It replaces the document, ‘‘De?nitions of Infertility (...) and Recurrent Pregnancy Loss: a Committee Opinion,’’ last published in 2013 (Fertil Steril 2013;99:63). (Fertil Steril 2020;113:533–5.2019 by American Society for Reproductive Medicine.) El resumen está disponible en Español al?nal del artículo. Discuss: You can discuss this article with its authors and other readers at https://www.fertstertdialog.com/users/16110-fertility- and-sterility/posts/56482-29354 I nfertility is categorized as a disease bytheWorldHealthOrganization,a designationsupportedbynumerous

2020 Society for Assisted Reproductive Technology

17. Clinical Guideline: Perinatal care of suspected or confirmed COVID-19 in pregnant women

or vaginal fluid 11 (although few women have been tested) • SARS-CoV-2 has been detected in stools 12-14 Physiology of pregnancy and COVID-19 • Immunosuppression of pregnancy may impact severity of symptoms 15 • Due to physiological changes, when compared with their non-pregnant counterparts, pregnant women with lower respiratory tract infections may experience worse outcomes (e.g. preterm birth, fetal growth restriction and perinatal mortality) 16,17 • Increased oxygen demands of pregnancy may increase (...) Clinical Guideline: Perinatal care of suspected or confirmed COVID-19 in pregnant women Maternity and Neonatal C linical G uideline Queensland Health Clinical Excellence Queensland Maternity care for mothers and babies during the COVID-19 pandemic (V2 draft v0.01) Queensland Clinical Guideline: Maternity care for mothers and babies during the COVID-19 pandemic Refer to online version, destroy printed copies after use Page 2 of 29 Document title: Maternity care for mothers and babies during

2020 Queensland Health

18. Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening

of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Collapse All Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some races/ethnicities. Bacterial vaginosis during pregnancy has been associated with adverse obstetrical outcomes including preterm delivery, early (...) vaginal clindamycin) presented results for preterm delivery at less than 34 weeks, and the results were mixed. Potential Harms The harms of screening for bacterial vaginosis in pregnant persons and treatment with antibiotics generally involve adverse effects such as gastrointestinal upset and vaginal candidiasis. Four observational studies and 2 large meta-analyses of observational studies on the use of metronidazole during pregnancy for any reason (not limited to bacterial vaginosis) reported

2020 U.S. Preventive Services Task Force

19. Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum

Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum Translating evidence into best clinical practice Queensland Health NOTICE OF UPDATE DURING COVID-19 PANDEMIC DATE 14 April 2020 TOPIC Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum APPLIES TO All pregnant and postnatal women irrespective of COVID-19 status RATIONALE During the COVID-19 pandemic • Supports social distancing (...) macrosomia (birth weight > 4500 g or > 90th percentile • Previous perinatal loss • Polycystic ovarian syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy COVID-19 pandemic • Applies to: Pregnant women regardless of COVID-19 status • Rationale: To support social distancing and minimise blood collection time (i.e not based on new evidence) • Implementation: Commence as practical and convenient. Seek expert advice as clinically appropriate Check fasting FBG • At 24–28 weeks

2020 Queensland Health

20. FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak

FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) - Faculty of Sexual and Reproductive Healthcare Privacy notice This site makes use of cookies . If you continue we'll assume you are happy to receive them. FSRH CEU: information (...) to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) Share this article Published on: 26 March 2020 File size: 149kb PDF File type: Covid-19 (Coronavirus) FSRH CEU Individuals planning pregnancy during Covid-19: information to support healthcare

2020 Faculty of Sexual & Reproductive Healthcare